OCIPERLIMAB
UNII 7JNY4KV3NK

Substance Identification & Data

This profile provides standardized clinical and technical data for Ociperlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7JNY4KV3NK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2342597-93-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7JNY4KV3NK

CAS Registry Number

2342597-93-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OCIPERLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C170906

National Cancer Institute reference terminology for clinical and research data.

INN ID

11452

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-219

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ociperlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OCIPERLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TIGIT) (HUMAN-MUS MUSCULUS MONOCLONAL BGB-A1217 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BGB-A1217 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TIGIT (T-CELL IMMUNORECEPTOR WITH IG DOMAIN AND ITIM, V-SET IG MEMBER 9, VSIG9, V-SET AND TRANSMEMBRANE MEMBER 3, VSTM3)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-449) (VH (HOMO SAPIENS IGHV3-66*01 (88.8%)-(IGHD)-IGHJ4*01 (100%)) CDR-IMGT (8.8.12) (26-33.51-58.97-108) (1-119)-HOMO SAPIENS IGHG1*01 NG1M1, G1M17 (CH1 K120 (216) (120-217), HINGE 1-15 (218-232), CH2 (233-342), CH3 E12 (358), M14 (360) (343-447), CHS (448-449)) (120-449)), (222-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (87.4%)-IGKJ4*01 (100%)) CDR-IMGT (6.3.9) (27-32.50-52.89-97) (1'-107')-HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

OCIPERLIMAB [INN]

OCIPERLIMAB [USAN]

OCIPERLIMAB [WHO-DD]